Abstract
Recombinant adeno-associated viral (AAV) vectors have been successfully employed as the mode of gene delivery in several clinical trials for the treatment of inherited retinal diseases to date. The design of such vectors is critical in determining cellular tropism and level of subsequent gene expression that may be achieved following viral delivery. Here we describe a system for living retinal tissue extraction, ex vivo culture, viral transduction and assessment of transgene expression that may be used to assess viral constructs for gene therapy in the human retina at a preclinical stage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Mingozzi F, High KA (2011) Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12:341–355
Smith J, Ward D, Michaelides M et al (2015) New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review. Eye 29:1131–1140
Bainbridge JWB, Smith AJ, Barker SS et al (2008) Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 358:2231–2239
MacLaren RE, Groppe M, Barnard AR et al (2014) Retinal gene therapy in patients with choroideremia: Initial findings from a phase 1/2 clinical trial. Lancet 383:1129–1137
Ghazi NG, Abboud EB, Nowilaty SR et al (2016) Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Hum Genet 135:327–343
Mcclements ME, Maclaren RE (2013) Gene therapy for retinal disease. Transl Res 161:241–254
Loeb JE, Cordier WS, Harris ME et al (1999) Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum Gene Ther 10:2295–2305
Patricio MI, Barnard AR, Orlans HO et al (2017) Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2 mediated transduction of mouse and human retina. Mol Ther Nucleic Acids (in press)
McCarty DM (2008) Self-complementary AAV Vectors; advances and applications. Mol Ther 16:1648–1656
Petersen-Jones SM, Bartoe JT, Fischer AJ et al (2009) AAV retinal transduction in a large animal model species: comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector. Mol Vis 15:1835–1842
Asokan A, Schaffer DV, Samulski RJ (2012) The AAV vector toolkit: poised at the clinical crossroads. Mol Ther 20:699–708
Tolmachova T, Tolmachov OE, Barnard AR et al (2013) Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo. J Mol Med 91:825–837
De Silva SR, Issa PC, Singh MS et al (2016) Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4−/− mouse and bipolar cells in the rd1 mouse and human retina ex vivo. Gene Ther 23:767–774
Johnson TV, Martin KR (2008) Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. Invest Ophthalmol Vis Sci 49:3503–3512
Issa PC, Singh MS, Lipinski DM et al (2012) Optimization of in vivo confocal autofluorescence imaging of the ocular fundus in mice and its application to models of human retinal degeneration. Invest Ophthalmol Vis Sci 53:1066–1075
Acknowledgments
This work was supported by grants from the Medical Research Council, UK, Fight for Sight, UK, and the Wellcome Trust, UK.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Orlans, H.O., Edwards, T.L., De Silva, S.R., Patrício, M.I., MacLaren, R.E. (2018). Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy. In: Boon, C., Wijnholds, J. (eds) Retinal Gene Therapy. Methods in Molecular Biology, vol 1715. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7522-8_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7522-8_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7521-1
Online ISBN: 978-1-4939-7522-8
eBook Packages: Springer Protocols